The in vitro fertilization (IVF) market is on a remarkable growth trajectory, with its valuation expected to soar from USD 819.8 million in 2024 to an impressive USD 1,940.8 million by 2034. This robust expansion, driven by a high incidence of infertility and increasing demand for advanced reproductive technologies, is forecasted to occur at a compound annual growth rate (CAGR) of 9% from 2024 to 2034.
The projected growth underscores the critical role of IVF in addressing fertility challenges faced by millions of individuals and couples worldwide. As infertility rates continue to rise, the IVF market is poised to expand significantly, offering innovative solutions and hope to those seeking to start or expand their families.
Advancements in medical technology, greater societal acceptance, and supportive government policies are contributing to the increasing adoption of IVF procedures. The market’s growth is also fueled by rising awareness and accessibility of fertility treatments, ensuring that more people can benefit from these life-changing medical interventions.
The anticipated expansion of the IVF market reflects a broader trend towards prioritizing reproductive health and leveraging cutting-edge medical technologies to improve outcomes. As the industry evolves, it promises to deliver enhanced success rates, more personalized treatment plans, and improved patient experiences.
Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14305
IVF Market Dominates Infertility Treatment Landscape
Presently, the worldwide infertility treatment market is dominated by the in vitro fertilization sector. As more people and couples looking for reproductive solutions become aware of the advantages of IVF, this dominance is expected to grow.
This growth is primarily driven by two key factors:
- Rising Demand for IVF Procedures: A declining global fertility rate coupled with growing awareness about the improved success rates of IVF is leading to a surge in demand for these procedures.
- Increased Accessibility to Fertility Treatments: The rapid rise in the number of IVF clinics and hospitals worldwide is making fertility treatments more readily available, creating substantial growth opportunities within the market.
Some of the key takeaways from the report are highlighted below
- The demand for egg banking services is expected to surge considerably in the coming years
- Europe will lead in the in vitro fertilization banking services market throughout the forecast period
- Latin America will emerge lucrative in the in vitro fertilization banking services market in the coming years
- The rising demand for andrology services will augment growth prospects
- Fresh donor egg cycle services will remain highly sought-after among various egg banking services available
“The launch of advanced IVF techniques such as genetic diagnosis, three parent IVF, percutaneous epidydimal sperm aspiration, three-parent, and others are considered revolutionary findings in the field of medicine. Besides the rising prevalence of fertility concerns, increasing awareness among patients and their willingness to spend on advanced treatment procedures will create lucrative growth opportunities for the market.”
Competitive Landscape:
The worldwide in vitro fertilization industry is extremely competitive due to the existence of numerous regional and local firms. Leading in vitro fertilization (IVF) companies are constantly concentrating on growing their service and product offerings in order to profit. In addition, in order to obtain a competitive edge in the international IVF market, they have implemented a number of initiatives, including partnerships, mergers, acquisitions, collaborations, and the introduction of awareness campaigns. For example,
- In September 2029, Hamilton Thorne Ltd., a leading worldwide provider of precision instruments, consumables, software, and services to Assisted Reproductive Technologies (ART) and developmental biology research markets, received clearance to market GM501 wash media, its first Gynemed branded media product, in the USA
- In May 2021, Ro, the healthcare technology company, announced the acquisition of Modern Fertility, a high-growth reproductive health company.
- In September 2019, Fujifilm Irvine Scientific, Inc., launched Vit Kit-NX, a new vitrification solution for IVF.
Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-14305
Key Companies Covered:
Vitrolife, Thermo Fisher Scientific Inc, Cook Group, IVFtech ApS, Esco Micro, Genea Limited, Fujifilm Irvine Scientific, The Baker Company, and Kitazato Corporation.
Key Segments:
By Product:
- Equipment
- Reagents and Media
- Accessories
By Cycle:
- Fresh non-donor cycle
- Frozen non-donor IVF cycle
- Frozen donor IVF cycle
- Fresh donor IVF cycle
By End User:
- Fertility Clinics
- Hospitals & Surgical Centers
- Cryobank and Research Institutes
By Type:
- Conventional IVF
- IVF with ICSI
- IVF with Donor Eggs
- North America
- Latin America
- Middle East and Africa
- Asia Pacific
- Europe
Secure Your Market Analysis: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/14305
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
